鹽酸美沙酮市場：按劑型、應用、給藥途徑、分銷管道和地區分類

Methadone Hydrochloride Market, By Formulation, By Application, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2026年05月05日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，鹽酸美沙酮市值將達1.368億美元，2033年將達到1.863億美元。預計從2026年到2033年，其複合年成長率將達到4.5%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1.368億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	4.50%	2033年市場規模預測：	1.863億美元

美沙酮是一種合成麻醉性鎮痛藥，屬於鴉片類藥物。這類鴉片類藥物的藥理作用與氫可酮在性質上相似。美沙酮常用於鎮痛，也用於藥物成癮的戒斷和維持治療。疼痛的形式多種多樣，包括手術或肌肉緊張引起的疼痛。對於患有嚴重慢性疼痛的患者，通常會給予小劑量美沙酮。美沙酮的作用機轉是改變大腦和神經系統對疼痛的反應。鴉片類藥物成癮是一個嚴重的公共衛生問題。

市場動態

主要企業正致力於透過併購來鞏固其在全球鹽酸美沙酮市場的地位。例如，2016年5月，Hikma Pharmaceuticals PLC收購了製藥公司Roxane Laboratories, Inc.。此次收購使Hikma得以從Roxane Laboratories, Inc.獲得鹽酸美沙酮，從而擴展了其鴉片類促效劑產品系列。

本次調查的主要特點

本報告分析了全球鹽酸美沙酮的現狀和未來市場潛力。鹽酸美沙酮市場按劑型、應用、給藥途徑、分銷管道和地區進行細分。
本報告對全球鹽酸美沙酮市場進行了詳細分析，並給出了預測期（2026-2033 年）的市場規模和複合年成長率（%）。
本報告揭示了各細分市場的潛在商機，並說明了該市場極具吸引力的投資提案矩陣。此外，報告還深入分析了市場促進因素、阻礙因素、機會、區域前景以及主要參與者所採取的競爭策略。
本報告根據以下參數對全球鹽酸美沙酮市場的主要參與者進行了分析：公司概況、財務業績、產品系列、地理分佈、主要發展和未來計劃。
透過利用本報告中提出的見解，企業行銷負責人和經營團隊將能夠就未來的市場擴張和行銷策略做出明智的決策。
本市場報告面向行業內的各種相關人員，包括投資者、產品開發商和製造商、經銷商、醫療機構、研究機構、新參與企業和金融分析師。
相關人員將在決策過程中受益於全球鹽酸美沙酮市場分析中使用的各種策略矩陣。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第9章競爭情勢

公司簡介
- Eli Lilly and Company
- Sanofi SA
- Hikma Pharmaceuticals PLC
- Mallinckrodt Pharmaceuticals
- Siegfried Holding AG
- Johnson Matthey
- Tianjin Central Pharmaceutical Co., Ltd
- Temad Co
- Embio LTD
- Harman Finochem Ltd
- Rusan Pharma Ltd

第10章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI4343

Methadone Hydrochloride Market is estimated to be valued at USD 136.8 Mn in 2026 and is expected to reach USD 186.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 136.8 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.50%	2033 Value Projection:	USD 186.3 Mn

Methadone, a synthetic narcotic analgesic is part of a category called opioids. This opioid has pharmacologic actions qualitatively similar to morphine. Methadone is generally used as a pain reliever and as a part of drug addiction detoxification and maintenance therapy. Pain can be of various types such as due to surgery, strain, and others. A person experiencing severe and chronic pain is given small doses of methadone, which encounters the pain by changing the way the brain and nervous system respond to pain. Opiate dependence is a major public health problem.

Market Dynamics

Key players are focusing on mergers and acquisitions to strengthen their position in the global methadone hydrochloride market. For instance, in May 2016, Hikma Pharmaceuticals PLC acquired Roxane Laboratories, Inc., a pharmaceutical company. Through this acquisition, the company expanded its product portfolio of opiate agonist by acquiring methadone hydrochloride from Roxane Laboratories, Inc

Key features of the study

This report studies the current scenario as well as the future market potential of methadone hydrochloride across the globe. The market for methadone hydrochloride has been segmented on the basis of formulation, application, route of administration, distribution channel, and region.
This report provides in-depth analysis of the global methadone hydrochloride market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2026-2033)
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, regional outlook, and competitive strategies adopted by the leading players.
It profiles leading players in the global methadone hydrochloride market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future market expansion and marketing tactics
Key companies covered as a part of this study are Eli Lilly and Company, Sanofi S.A, Hikma Pharmaceuticals PLC, Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Tianjin Central Pharmaceutical Co., Ltd, Temad Co, Embio LTD, Harman Finochem Ltd, and Rusan Pharma Ltd.
The global methadone hydrochloride market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
Stakeholders would greatly benefit in decision-making through various strategy matrices used in analyzing the global methadone hydrochloride market

Market Segmentation

By Formulation Insights (Revenue, USD Mn, 2021 - 2033)
- Tablet
- Solution
- Others
By Application Insights (Revenue, USD Mn, 2021 - 2033)
- Opiate Withdrawal
- Chronic Pain
- Others
By Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Oral
- Intravenous
By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players
- Eli Lilly and Company
- Sanofi S.A
- Hikma Pharmaceuticals PLC
- Mallinckrodt Pharmaceuticals
- Siegfried Holding AG
- Johnson Matthey
- Tianjin Central Pharmaceutical Co., Ltd
- Temad Co
- Embio LTD
- Harman Finochem Ltd
- Rusan Pharma Ltd

Table of Content

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Formulation
- Market Snapshot, By Application
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Drivers and Restraints
Opportunities
Impact Analysis
Recent Product launches and Approvals
Pipeline Analysis
Brand Analysis
Regulatory Scenario
PEST Analysis
Epidemiology
Reimbursement Scenario
Acquisition
Market Trend

4. Global Methadone Hydrochloride Market, By Formulation, 2021-2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Tablet
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Methadone Hydrochloride Market, By Application, 2021-2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Opiate Withdrawal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Chronic Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Methadone Hydrochloride Market, By Route of Administration, 2021-2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Methadone Hydrochloride Market, By Distribution Channel, 2021-2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Methadone Hydrochloride Market, By Region, 2021-2033 (USD Mn)

Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Countries, 2022-2033
North America
- Introduction
- Market Size and Forecast, By Formulation, 2021-2033 (USD Mn)
- Market Size and Forecast, By Application 2021-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Mn)
- Market Size and Forecast, By Country, 2021-2033 (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Formulation, 2021-2033 (USD Mn)
- Market Size and Forecast, By Application 2021-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Mn)
- Market Size and Forecast, By Country, 2021-2033 (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Formulation, 2021-2033 (USD Mn)
- Market Size and Forecast, By Application 2021-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Mn)
- Market Size and Forecast, By Country, 2021-2033 (USD Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Formulation, 2021-2033 (USD Mn)
- Market Size and Forecast, By Application 2021-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Mn)
- Market Size and Forecast, By Country, 2021-2033 (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Formulation, 2021-2033 (USD Mn)
- Market Size and Forecast, By Application 2021-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Mn)
- Market Size and Forecast, By Country, 2021-2033 (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Formulation, 2021-2033 (USD Mn)
- Market Size and Forecast, By Application 2021-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Mn)
- Market Size and Forecast, By Country/Region, 2021-2033 (USD Mn)
  - South Africa
  - Central Africa
  - North Africa

9. Competitive Landscape

Company Profiles
- Eli Lilly and Company
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Sanofi S.A
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Hikma Pharmaceuticals PLC
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Mallinckrodt Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Siegfried Holding AG
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Johnson Matthey
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Tianjin Central Pharmaceutical Co., Ltd
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Temad Co
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Embio LTD
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Harman Finochem Ltd
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Rusan Pharma Ltd
  - Company Overview
  - Product Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
  - Analyst View